RISE Global Obesity Industry TOP2+ (476310)
NAV
10,099KRW
-117.81하락 (-1.15%)
Market Price per share (KRW)
9,980KRW
-120하락 (-1.19%)
※ t-1 last price
trading volume
5,589shares
AUM
KRW 6billion
KEY POINT
Focus on investing in key corporations of the global megatrend in obesity treatment.
KEY POINT
It allocates 28% each to the market's First Mover, Eli Lilly (LLY) and Novo Nordisk (NVO), while the rest is invested in global pharmaceutical and fitness-related companies.
ETF Name (code) | Benchmark Index | Inception date | Creation Unit | AUM (KRW) |
---|---|---|---|---|
KB RISE Global Obesity Care Industry TOP2+ ETF
(476310) |
KEDI Global Obesity Care Industry Top2+ Index | 2024.02.27 | 50,000 | 6,059,525,023 |
Trustee | Market Price per share (KRW) | NAV | Trading Volume (shares) | |
한국씨티은행 |
9,980
※ t-1 last price |
10,099 | 5,589 |
Total Expense Ratio | Distribution Frequency |
---|---|
Year 0.35% (Designated participating company : 0.01%, Collective investment : 0.3%, trust : 0.02%, General affairs : 0.02%) | Last business day of January, April, July and October, and end of accounting period (occasional payment) |
Authorized Participants | Liquidity Providers |
Kiwoom Securities, NH Investment & Securities, Shinhan Investment & Securities, Korea Investment & Securities, Mirae Asset Securities | Kiwoom Securities, NH Investment & Securities, Shinhan Investment & Securities, Korea Investment & Securities, Mirae Asset Securities |
ETF Name(Code) | Benchmark Index |
---|---|
KB RISE Global Obesity Care Industry TOP2+ ETF (476310) |
KEDI Global Obesity Care Industry Top2+ Index |
Inception date | Creation Unit |
2024.02.27 | 50,000 |
AUM(0.1 billion) (KRW) | Trustee |
6,059,525,023 | 한국씨티은행 |
Market Price per share (KRW) | iNAV per share (KRW) |
9,980
※ t-1 last price |
10,099 |
Trading Volume (shares) | |
5,589 |
Index Introduction
The KEDI Global Obesity Industry Top2+ Index is comprised of companies in the obesity industry, a global megatrend. It allocates 28% of its composition to Eli Lilly (LLY) and Novo Nordisk (NVO), the first movers in the obesity treatment market, and the remainder to global pharmaceutical companies and fitness-related enterprises, utilizing a market capitalization-weighted method.
TOP 10 Holdings
Rank | Name | Weight (%) |
---|---|---|
1 | ELI LILLY & CO | 30.18 |
2 | NOVO NORDISK AS SPONS ADR | 25.42 |
3 | ASTRAZENECA PLC SPONS ADR | 7.85 |
4 | ABBOTT LABORATORIES | 7.62 |
5 | MERCK & CO.INC | 7.62 |
6 | NORVARTIS AG ADR | 6.85 |
7 | PFIZER INC | 4.61 |
8 | DICKS SPORTING GOODS INC | 3.00 |
9 | PLANET FITNESS INC CL A | 2.95 |
10 | LULULEMON ATHLETICA INC | 2.91 |
proportion by sectors
*The proportion of investment stocks
Rank | Name | Weight (%) |
---|---|---|
1 | Health Care | 65.95 |
2 | Etc | 31.08 |
3 | Consumer Discretionary | 2.97 |
- Investment notice
- - The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- - Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- - Past performance does not guarantee future profits.
- - In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- - Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- - Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.